1Kasielski M, Nowak D. Long-term administration of N- acetylcysteine decreases hydrogen peroxide exhalation in subiects with chronic obstructive pulmonary disease[J]. Respir Med,2001,95(6):448-456.
2Ko FW, Lau CY, Leung TF, et al. Exhaled breath condensate levels of 8-isoprostane, growth related on cogene alpha and monocyte chemoattractant protein-1 in patients with chronic obstructive pulmonary disease[J]. Respir Med, 2006,100 (4) : 630-638.
3Karadag F, Cildag O, Altinisik M, et al. Trace elements as a component of oxidative tress in COPD[J]. Respirology, 2004,9 (1) :33-37.
4Rytila P, Rehn T, Ilumets H, et al. Increased oxidative stress in asymptomatic current chronic smokers and GOLD stage 0 COPD[J]. Respir Res,2006,7:69.
5R M Leach, M L Forsling. The effect of changes in arterial PCO2 on neuroendocrine function in man [J]. Exp Physiol, 2004, 89(3):287.
6Valli G, Fedeli A, Antonucci R, et al. Water and sodium imbalance in COPD patients [J]. Monaldi Arch Chest Dis,2004,61(2):112.
7Ashitani J, Mukae H, Arimura Y, et al. Elevated plasmap rocoagulant and fibrinolytic markers in patients with chronic obstructive pulmonary disease[J]. Intern Med, 2002,41 (3)181.
8CooK N S, Ubben D. Fibrinogcn as a major risk in cardiovascular disease [J]. Trends Pharmacol Sci, 1990,11 (4) : 444.
9Ernst E. Fibrinogen: an important risk factor for atherothrombotic diseases [J]. Ann Med, 1994, 26 (1) : 15.
10Danl M, Tybjaerg Hansen A, Vestbo J, et al. Elevated plasma fibrinogen associated with reduced pulmonary function and increased risk of chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med, 2001, 15,164(6):1008.
4Siafakas NM, Vermeire P, Pride NB, et al. Optimal and manage- ment of COPD : a consensus statement of ERS. Eur Respir J, 1995, 8 ( 5 ) : 1398-1420.
5陆再英,钟南山主编.内科学.7版.北京:人民卫生出版社,2008:778-779.
6Mapel DW,Nelson LS,Lydick E. Survival among COPD patients using fluticasone/salmeterol in combination versus other inhaled steroids and bronchodilators alone[J].Journal of Chronic Obstructive Pulmonary Disease,2007,(02):127-134.
